Price $350.01 |
Market Cap
10.71B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
12.4
|
P/B
1.84
|
P/S
4.78
|
Dividend %
-
|
|
P/CF
79.2
|
P/FCF
14.6
|
Op. Cash Flow
955.5K
|
FCF
15.4
|
|
Op. Margin
49.90%
|
Net Margin
40.80%
|
ROE
17.10%
|
ROI
13.50%
|
|
ROA
13.80%
|
EPS Growth
23.70%
|
Current Ratio
9.8
|
Debt/Equity
16.70%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Chromadex Corp (CDXC) | $3.26 | - | - | 105.8M | Strong Buy |
| iCAD Inc (ICAD) | $1.51 | - | - | 38.2M | Strong Buy |
| Aytu Biopharma Inc (AYTU) | $2.40 | - | - | 14.8M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $2.73 | - | - | 183.6M | Strong Buy |
| PetIQ Inc (PETQ) | $30.58 | - | - | 564.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
